Milder symptoms and shorter course in patients with re-positive COVID-19: A cohort of 180 patients from Northeast China.

Li, Hongyan; Zhu, Mingqin; Zhang, Peng; Yan, Xingjian; Niu, Junqi; Wang, Zhenyu; Cao, Jie

Li, Hongyan; Zhu, Mingqin; Zhang, Peng; Yan, Xingjian; Niu, Junqi; Wang, Zhenyu; Cao, Jie.

Afiliación

Li H; Department of Nursing, The First Hospital of Jilin University, Changchun, China.
Zhu M; Department of Neurology, The First Hospital of Jilin University, Changchun, China.
Zhang P; Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, China.
Yan X; Department of Urology, The First Hospital of Jilin University, Changchun, China.
Niu J; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory of Zoonotic Disease, Department of Hepatology, Center of Infectious Disease and Pathogen Biology, The First Hospital of Jilin University, Changchun, China.
Wang Z; Department of Spinal Surgery, The First Hospital of Jilin University, Changchun, China.
Cao J; Department of Neurology, The First Hospital of Jilin University, Changchun, China.

Front Microbiol ; 13: 989879, 2022.

Article en En | MEDLINE | ID: mdl-36304945

Palabras clave

COVID-19; Northeast China; anti-CoV IgG; re-positive; underlying disease

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Front Microbiol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google